Aster CMI Hospital is one of the top-tier medical institutions in the world and is at the forefront of cancer treatment technology. It has become a leader in targeted therapy, a new type of personalized medicine that provides customized treatments to each patient's specific needs. Targeted cancer therapies are a treatment designed to target specific cancer cells while leaving surrounding non-cancerous cells unharmed. This form of therapy is very beneficial because it eliminates the need for more invasive surgeries and traditional chemotherapy treatments that usually come with greater risks and side effects.
At Aster CMI, many cancer patients undergo targeted therapy after a medical evaluation involving several sophisticated tests. The hospital's medical team can determine the patient's cancer biosecurity through these tests, providing valuable insights into how best to tailor the treatment. The hospital then designs individually tailored treatments that directly target the specific type of cancer cells, enabling targeted, effective, and minimally invasive treatment. Overall, targeted therapy at Aster CMI is an innovative and effective way of administering cancer treatments. By recognizing the diversity in cancer treatments and honing in on the specific characteristics of each case, doctors can provide personalized care that offers the best chance for successful recovery.
FAQ's
At Aster Hospitals we provide the highest quality of care and a transformative experience for all your healthcare needs. With our network of multi-speciality hospitals, specialised doctors, and world-class technology, we bring global standards of medical care to our patients.
How does targeted therapy work?
Targeted therapy works by targeting pathways that allow all the cancer cells to grow, divide, and spread while sparing normal cells from damage.
What types of cancer can be treated with targeted therapy?
Targeted therapies can treat many types of cancer, including breast, colorectal, lung, and prostate cancers.
Is targeted therapy safe?
Targeted therapy has been rigorously tested and is generally safe for patients. However, as with any medication, there may be side effects such as fatigue, nausea, and hair loss.
Can I still have surgery if I am receiving targeted therapy?
Surgery may still be an option while receiving targeted therapy, depending on the type of cancer and the patient's situation.
Will targeted therapy work for everyone?
No, targeted therapy is not necessarily successful for all patients. Your doctor will determine if it is an appropriate treatment for you.
What should I do if I experience any side effects from targeted therapy?
Contact your doctor immediately if you experience any side effects from targeted therapy.
How long does targeted therapy usually take?
The time needed to complete targeted therapy will vary and depends on the type of cancer being treated and the patient's response to treatment.
What is targeted therapy?
Targeted therapy uses drugs to target specific proteins and genes that aid in the growth and spread of cancer cells.
Is targeted therapy better than chemotherapy?
Targeted therapy can be more effective than chemotherapy, targeting only the cancer cells and not damage healthy cells.
Are there any long-term side effects of targeted therapy?
Long-term side effects of targeted therapy can include a higher risk of infection, nausea, fatigue.
What are the costs associated with targeted therapy?
The cost of targeted therapy will depend on the type of therapy used. It may be covered by insurance, depending on the policy.
How will I know if I am responding to targeted therapy?
Your doctor will monitor you closely and perform tests to determine whether the treatment works.
What are the risks of targeted therapy?
As with any cancer treatment, there are risks associated with targeted therapy, such as complications from drug interactions, allergic reactions, or changes in blood cell counts.
Can I still have surgery if I am receiving targeted therapy?
Surgery may still be an option while receiving targeted therapy, depending on the type of cancer and the patient's situation.